Q2 2025 Organigram Global Inc Earnings Call Transcript
Key Points
- Organigram Global Inc (OGI) reported a record-breaking quarter by revenue, with gross sales up 79% year-over-year, surpassing $100 million for the first time.
- The company achieved a leading market share in Canada, particularly in the vape category with a 21.7% share, and maintained strong positions in flower and pre-rolls.
- International sales increased by 177% year-over-year, driven by strong demand in markets like Germany and Australia.
- The integration of the Motif acquisition is progressing well, with expected synergies now estimated at $15 million annually, up from the previous $10 million.
- Organigram Global Inc (OGI) is expanding its presence in the US hemp-derived THC beverage market, with products now distributed in 10 states and carried by major retailers.
- Despite the record revenue, the company experienced negative cash flow this quarter, primarily due to working capital investments and the Collective Project acquisition.
- Margins from the Motif acquisition were lower than the core business, impacting overall adjusted gross margin.
- The company faces a fragmented and competitive market in Canada, with the top three LPs holding only 27% of total market share.
- There is potential for price compression in international markets, as value flower is starting to appear in Germany.
- The US hemp-derived THC beverage market is highly competitive, with many brands and the need for significant investment to drive growth and consumer adoption.
Good morning. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Organigram Global second quarter fiscal 2025 earnings conference call. (Operator Instructions) Thank you. Max Schwartz, you may begin your conference.
Thank you very much, and good morning, everyone. Thanks for joining us today. As a reminder, this conference call is being recorded, and a recording will be available on Organigram's website 24 hours after today's call.
Listeners should be aware that today's call will include estimates and other forward-looking information from which the company's actual results could differ. Please review the cautionary language in our press release dated May 12, 2025, on various factors, assumptions, and risks that could cause our actual results to differ.
Further references will be made to certain non-IFRS measures during this call, including adjusted EBITDA, adjusted gross margin, and adjusted gross margin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
